← All trials
NCT05224492
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 21, 2022
- Primary completion
- Jul 21, 2022
- Completion date
- Sep 21, 2022
- First posted
- Feb 4, 2022
- Last posted
- Feb 7, 2022
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sunshine Specialty Health CareLead sponsor
- Sunshine Specialty Health CareOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.